Titre : Chromosomes humains de la paire 3

Chromosomes humains de la paire 3 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Research Design
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 3 : Questions médicales les plus fréquentes", "headline": "Chromosomes humains de la paire 3 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Chromosomes humains de la paire 3 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-04", "dateModified": "2025-04-29", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 3" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Chromosomes humains 1-3", "url": "https://questionsmedicales.fr/mesh/D002900", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains 1-3", "code": { "@type": "MedicalCode", "code": "D002900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.235" } } }, "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 3", "alternateName": "Chromosomes, Human, Pair 3", "code": { "@type": "MedicalCode", "code": "D002893", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hoa H Chuong", "url": "https://questionsmedicales.fr/author/Hoa%20H%20Chuong", "affiliation": { "@type": "Organization", "name": "Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA." } }, { "@type": "Person", "name": "Arang Rhie", "url": "https://questionsmedicales.fr/author/Arang%20Rhie", "affiliation": { "@type": "Organization", "name": "Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA." } }, { "@type": "Person", "name": "Sergey Koren", "url": "https://questionsmedicales.fr/author/Sergey%20Koren", "affiliation": { "@type": "Organization", "name": "Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA." } }, { "@type": "Person", "name": "Erik Garrison", "url": "https://questionsmedicales.fr/author/Erik%20Garrison", "affiliation": { "@type": "Organization", "name": "Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN, USA." } }, { "@type": "Person", "name": "Jennifer L Gerton", "url": "https://questionsmedicales.fr/author/Jennifer%20L%20Gerton", "affiliation": { "@type": "Organization", "name": "Stowers Institute for Medical Research, Kansas City, MO, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Time to STEP UP: methods and findings from the development of guidance to help researchers design inclusive clinical trials.", "datePublished": "2024-10-02", "url": "https://questionsmedicales.fr/article/39358688", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12874-024-02342-y" } }, { "@type": "ScholarlyArticle", "name": "Implementing a combined Delphi and Focus Group qualitative methodology in Nexus research designs-The case of the WEFE Nexus in Apokoronas, Crete.", "datePublished": "2022-07-14", "url": "https://questionsmedicales.fr/article/35834515", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0271443" } }, { "@type": "ScholarlyArticle", "name": "Lessons learned in the practice of community-based participatory research with community partner collaboration in study design and implementation: the community scientist model.", "datePublished": "2023-04-21", "url": "https://questionsmedicales.fr/article/37081154", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10552-023-01699-7" } }, { "@type": "ScholarlyArticle", "name": "Research designs and instruments to detect physiotherapy overuse of low-value care services in low back pain management: a scoping review.", "datePublished": "2023-02-23", "url": "https://questionsmedicales.fr/article/36823581", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-023-09166-4" } }, { "@type": "ScholarlyArticle", "name": "Enhancing and assessing fidelity in the TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD) trial: development of methods and recommendations for research design.", "datePublished": "2022-06-06", "url": "https://questionsmedicales.fr/article/35668365", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12874-022-01642-5" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Chromosomes", "item": "https://questionsmedicales.fr/mesh/D002875" }, { "@type": "ListItem", "position": 5, "name": "Chromosomes de mammifère", "item": "https://questionsmedicales.fr/mesh/D033481" }, { "@type": "ListItem", "position": 6, "name": "Chromosomes humains", "item": "https://questionsmedicales.fr/mesh/D002877" }, { "@type": "ListItem", "position": 7, "name": "Chromosomes humains 1-3", "item": "https://questionsmedicales.fr/mesh/D002900" }, { "@type": "ListItem", "position": 8, "name": "Chromosomes humains de la paire 3", "item": "https://questionsmedicales.fr/mesh/D002893" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Chromosomes humains de la paire 3 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Chromosomes humains de la paire 3", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Chromosomes humains de la paire 3", "description": "Comment diagnostiquer une anomalie du chromosome 3 ?\nQuels tests génétiques sont utilisés pour le chromosome 3 ?\nQuels signes indiquent un problème avec le chromosome 3 ?\nLes échographies peuvent-elles détecter des anomalies chromosomiques ?\nQuel rôle joue le conseil génétique dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D002893?mesh_terms=Research+Design&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Chromosomes humains de la paire 3", "description": "Quels symptômes sont associés aux anomalies du chromosome 3 ?\nLes anomalies du chromosome 3 affectent-elles le développement physique ?\nY a-t-il des symptômes neurologiques liés au chromosome 3 ?\nLes troubles du comportement sont-ils fréquents ?\nLes anomalies du chromosome 3 peuvent-elles causer des problèmes cardiaques ?", "url": "https://questionsmedicales.fr/mesh/D002893?mesh_terms=Research+Design&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Chromosomes humains de la paire 3", "description": "Peut-on prévenir les anomalies chromosomiques ?\nQuel rôle joue la santé maternelle dans la prévention ?\nLes tests prénataux peuvent-ils prévenir des anomalies ?\nL'éducation génétique est-elle importante ?\nLes vaccinations peuvent-elles prévenir des anomalies ?", "url": "https://questionsmedicales.fr/mesh/D002893?mesh_terms=Research+Design&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Chromosomes humains de la paire 3", "description": "Quels traitements sont disponibles pour les anomalies du chromosome 3 ?\nLa chirurgie est-elle une option pour les malformations ?\nLes médicaments peuvent-ils aider les symptômes ?\nComment la thérapie comportementale aide-t-elle ?\nY a-t-il des traitements spécifiques pour les retards de développement ?", "url": "https://questionsmedicales.fr/mesh/D002893?mesh_terms=Research+Design&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Chromosomes humains de la paire 3", "description": "Quelles complications peuvent survenir avec des anomalies du chromosome 3 ?\nLes anomalies chromosomiques augmentent-elles le risque de cancer ?\nY a-t-il des complications psychologiques ?\nLes complications affectent-elles la qualité de vie ?\nLes soins de santé sont-ils plus complexes ?", "url": "https://questionsmedicales.fr/mesh/D002893?mesh_terms=Research+Design&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Chromosomes humains de la paire 3", "description": "Quels sont les facteurs de risque pour les anomalies du chromosome 3 ?\nL'exposition à des toxines influence-t-elle les anomalies ?\nLes maladies génétiques familiales sont-elles un facteur ?\nLe mode de vie peut-il affecter les risques ?\nLes infections pendant la grossesse sont-elles un risque ?", "url": "https://questionsmedicales.fr/mesh/D002893?mesh_terms=Research+Design&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie du chromosome 3 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un caryotype ou des tests génétiques spécifiques peuvent révéler des anomalies." } }, { "@type": "Question", "name": "Quels tests génétiques sont utilisés pour le chromosome 3 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de microdélétion et les analyses de SNP sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent un problème avec le chromosome 3 ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des retards de développement ou des malformations peuvent indiquer des anomalies." } }, { "@type": "Question", "name": "Les échographies peuvent-elles détecter des anomalies chromosomiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines anomalies peuvent être suspectées lors des échographies prénatales." } }, { "@type": "Question", "name": "Quel rôle joue le conseil génétique dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le conseil génétique aide à interpréter les résultats et à évaluer les risques." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux anomalies du chromosome 3 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des retards mentaux, des malformations et des troubles du comportement." } }, { "@type": "Question", "name": "Les anomalies du chromosome 3 affectent-elles le développement physique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des malformations physiques et des problèmes de croissance." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques liés au chromosome 3 ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies peuvent causer des troubles neurologiques comme l'épilepsie." } }, { "@type": "Question", "name": "Les troubles du comportement sont-ils fréquents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles du comportement peuvent être observés chez les personnes affectées." } }, { "@type": "Question", "name": "Les anomalies du chromosome 3 peuvent-elles causer des problèmes cardiaques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies sont associées à des malformations cardiaques congénitales." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies chromosomiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies ne peuvent pas être prévenues, mais le conseil génétique aide." } }, { "@type": "Question", "name": "Quel rôle joue la santé maternelle dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne santé maternelle avant et pendant la grossesse peut réduire les risques." } }, { "@type": "Question", "name": "Les tests prénataux peuvent-ils prévenir des anomalies ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Ils permettent de détecter des anomalies, mais ne les préviennent pas." } }, { "@type": "Question", "name": "L'éducation génétique est-elle importante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide les familles à comprendre les risques et les options disponibles." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles prévenir des anomalies ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne préviennent pas les anomalies chromosomiques, mais protègent la santé." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les anomalies du chromosome 3 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend des symptômes et peut inclure thérapies physiques et éducatives." } }, { "@type": "Question", "name": "La chirurgie est-elle une option pour les malformations ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la chirurgie peut être nécessaire pour corriger certaines malformations physiques." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider les symptômes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être prescrits pour gérer des symptômes comme l'épilepsie." } }, { "@type": "Question", "name": "Comment la thérapie comportementale aide-t-elle ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut améliorer les compétences sociales et réduire les comportements problématiques." } }, { "@type": "Question", "name": "Y a-t-il des traitements spécifiques pour les retards de développement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes d'intervention précoce peuvent aider à améliorer le développement." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des anomalies du chromosome 3 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des problèmes de santé chroniques et des retards." } }, { "@type": "Question", "name": "Les anomalies chromosomiques augmentent-elles le risque de cancer ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies peuvent être associées à un risque accru de certains cancers." } }, { "@type": "Question", "name": "Y a-t-il des complications psychologiques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles psychologiques peuvent survenir, nécessitant un suivi." } }, { "@type": "Question", "name": "Les complications affectent-elles la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent avoir un impact significatif sur la qualité de vie des individus." } }, { "@type": "Question", "name": "Les soins de santé sont-ils plus complexes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec des anomalies chromosomiques peuvent nécessiter des soins spécialisés." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies du chromosome 3 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge maternel avancé et des antécédents familiaux augmentent les risques." } }, { "@type": "Question", "name": "L'exposition à des toxines influence-t-elle les anomalies ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certaines toxines pendant la grossesse peut augmenter les risques." } }, { "@type": "Question", "name": "Les maladies génétiques familiales sont-elles un facteur ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies génétiques peuvent augmenter le risque d'anomalies." } }, { "@type": "Question", "name": "Le mode de vie peut-il affecter les risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain peut réduire certains risques d'anomalies chromosomiques." } }, { "@type": "Question", "name": "Les infections pendant la grossesse sont-elles un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent augmenter le risque d'anomalies chromosomiques." } } ] } ] }

Sources (10000 au total)

Time to STEP UP: methods and findings from the development of guidance to help researchers design inclusive clinical trials.

It is important to design clinical trials to include all those who may benefit from the intervention being tested. Several frameworks have been developed to help researchers think about the barriers t... Development of the STEP UP guidance had five phases: (1) Scoping literature review, (2) 'roundtable' discussion meetings, (3) redesign of trials, (4) interviews and (5) guidance document development, ... Over 40 experts contributed to the ACCESS project-patients and the public, clinicians, NHS research staff, trialists and other academics. The scoping review identified several strategies being used to... Researchers should consider inclusivity to shape initial trial design decisions. Trial teams and funders need to ensure that trials are given both the resources and time needed to implement the STEP U...

Lessons learned in the practice of community-based participatory research with community partner collaboration in study design and implementation: the community scientist model.

Engagement of community participation is an innovative driver of modern research. However, to benefit the communities being studied, it is imperative to continuously evaluate ethical considerations, t...

Research designs and instruments to detect physiotherapy overuse of low-value care services in low back pain management: a scoping review.

The provision of low-value physiotherapy services in low back pain management is a known but complex phenomenon. Thus, this scoping review aims to systematically map existing research designs and inst... The development of this review is guided by the analysis framework of Arksey and O'Malley. A two-stage, audited search strategy was performed in Medline (PubMed), Web of Science, and google scholar. A... Thirty-three articles met the inclusion criteria. Seventy-nine percent of articles focused on the appropriateness of physiotherapeutic treatments, followed by education and information (30%), the diag... Identified research on low-value physiotherapy care in low back pain management was widely unidimensional. Most articles focused on the effectiveness domain of care and investigated the provider persp... This review has been registered on open science framework ( https://osf.io/vzq7k https://doi.org/10.17605/OSF.IO/PMF2G )....

Enhancing and assessing fidelity in the TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD) trial: development of methods and recommendations for research design.

Development of complex interventions for management of chronic conditions has become increasingly common, with guidance now provided. Fidelity (whether the intervention is designed, delivered and rece... Using the National Institute for Health Behaviour Change Consortium (NIH BCC) framework of fidelity, a set of enhancement strategies and a fidelity measurement strategy were developed with input from ... Hiring of respiratory professionals to the initial training programme was successful, with 44% of those expressing initial interest in being a Facilitator successfully completing the process. Video re... Addressing fidelity in complex intervention trials is a time and resource intensive process but has significant potential to increase understanding of results and strengthen the evidence base for effe... ISRCTN59537391 . Registered on 20 March 2017. Trial protocol version 6.0, 22 April 2018. Process evaluation protocol version 4.0, 1 November 2020....

A youth-centred approach to improving engagement in HIV services: human-centred design methods and outcomes in a research trial in Kisumu County, Kenya.

IntroductionInnovative interventions are needed to improve HIV outcomes among adolescents and young adults (AYAs) living with HIV. Engaging AYAs in intervention development could increase effectivenes... We applied an iterative, four-phased HCD process in Kenya that included: (1) systematic review of extant knowledge, (2) prioritisation of design challenges, (3) a co-creation workshop and (4) translat... Twenty-two participants engaged in the 4-day workshop. Co-creation activities yielded recommendations for improving planned interventions (eg, message frequency and content; strategies to engage hard-... Research employing HCD among youth can improve interventions preimplementation through empathy, youth-led inquiry and real-time problem solving. Peer navigation may be most influential in improving re...

Research designs and instruments to detect physiotherapy overuse of low-value care services in low back pain management: a scoping review protocol.

The provision of low-value care services in low back pain management is a problem of global scope. Inappropriate imaging, overmedication, and overused invasive therapies are prevalent in physician ser... The development of this scoping review is guided by the Arksey and O'Malley framework. A two-step, peer-reviewed search strategy in accordance with the PRESS checklist will be conducted on MEDLINE (Pu... Results of this scoping review will help researchers to systematically select overuse measures referring to aspects of the overuse typology, specific healthcare settings, and physiotherapy services. I... This protocol has been registered on the open science framework ( https://doi.org/10.17605/OSF.IO/PMF2G )....

Protocol for a meta-research study of protocols for diet or nutrition-related trials published in indexed journals: general aspects of study design, rationale and reporting limitations.

The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) reporting guideline establishes a minimum set of items to be reported in any randomised controlled trial (RCT) protocol.... We will conduct a meta-research study of RCT protocols published in journals indexed in at least one of six selected databases between 2012 and 2022. We have run a search in PubMed, Embase, CINAHL, We... This study will undertake a secondary analysis of published data and does not require ethical approval. The results will be disseminated through journals and conferences targeting stakeholders involve...

Qualitative longitudinal research in health research: a method study.

Qualitative longitudinal research (QLR) comprises qualitative studies, with repeated data collection, that focus on the temporality (e.g., time and change) of a phenomenon. The use of QLR is increasin... This method study used an adapted scoping review design. Articles were eligible if they were written in English, published between 2017 and 2019, and reported results from qualitative data collected a... A total of 299 articles were included. There was great variation among the articles in the use of methodological traditions, type of data, length of data collection, and components of longitudinal dat... QLR is often used in large complex studies. Some articles were thoroughly designed to capture time/change throughout the methodology, aim and data collection, while other articles included few element...